The CORE update lists nine outbreak and adverse event postings. The outbreak of
Clostridium botulinum (ref #1383), linked to a Nara Organics Whole Milk Powdered Infant Formula, has prompted the FDA to initiate an inspection. FDA updated the outbreak advisory on June 26, 2026, with investigation updates. The multistate outbreak of three confirmed infant botulism illnesses from three states: California, Pennsylvania, and Washington. No new cases have been added to the investigation since the initial notice was published on June 13, 2026. FDA conducted inspections at the two firms that manufacture Nara Organics Whole Milk Organic Infant Formula in Europe. At the conclusion of both inspections, observations citing deficiencies were issued to both facilities. FDA conducted inspections at the two firms that manufacture Nara Organics Whole Milk Organic Infant Formula in Europe. At the conclusion of both inspections, observations citing deficiencies were issued to both facilities. FDA conducted inspections at the two firms that manufacture Nara Organics Whole Milk Organic Infant Formula in Europe. At the conclusion of both inspections, observations citing deficiencies were issued to both facilities.
A new outbreak of E. coli O157:H7 (ref # 1382) linked to an unidentified product has been added to the table. FDA has initiated a traceback. The outbreak of Listeria monocytogenes (ref #1380) linked to requeson/soft ricotta cheese: FDA updated the outbreak advisory on June 29, 2026, with investigation updates, including a new recall of repackaged requeson cheese. As of June 15, 2026, six requeson cheese samples and one environmental sample collected by the Maryland Department of Health tested positive for Listeria monocytogenes and matched the outbreak strain. On June 24, 2026, a second environmental sample from Clover Hill Dairy, LLC, collected by Maryland state partners, also tested positive for Listeria monocytogenes and matched the outbreak strain.
The outbreak of Salmonella Enteritidis (ref #1378) linked to an unidentified product has increased the case count from 70 to 77. For the outbreak of Salmonella Typhimurium & Newport (ref #1358) linked to moringa leaf powder, FDA updated the outbreak advisory on June 30, 2026, with investigation updates. Two ingredient samples tested positive for Salmonella, but did not match the outbreak strain. While not connected to the outbreak, these ingredients do contain Salmonella. As a result, Total Nutrition Inc. recalled TNVitamins Organic Moringa Capsules 1,200 mg lot 2800 Exp: 2/2028 and TNVitamins-brand 100% Moringa Powder lot 2782 Exp: 5/2028.
Due to the outbreaks of Cyclospora (refs #1375 and #1381) linked to an unidentified product, the FDA has initiated sampling. @ https://www.fda.gov/food/outbreaks-foodborne-illness/investigations-foodborne-illness-outbreaks?utm_medium=email&utm_source=govdelivery
